Meta-analysis of 8 RCTs (636 participants) with depression: facial botulinum toxin A injection reduced depressive symptoms vs controls (SMD -0.81), beating placebo and comparable to sertraline; high-dose pan-facial injection and anxiety scores showed no significant difference.
Meta-analysisn = 636
Gao et al. Antidepressant effects of facial botulinum toxin a injections: Insights from randomized controlled trials